Yuan‐Bin Yu

661 citations
35 papers · 458 indexed · h-index 12
Topics
Multiple Myeloma Research and Treatments (7 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers)Cancer Treatment and Pharmacology (4 papers)
Partner nations
TaiwanBelarusGreece

In The Last Decade

Yuan‐Bin Yu

33 papers receiving 449 citations

Peers

Yuan‐Bin Yu
Comparison fields: 5 of 82
  • Hematology 154
  • Molecular Biology 129
  • Oncology 102
  • Epidemiology 80
  • Internal Medicine 52
Replace Andrzej Rydzewski with:
Andrzej Rydzewski Poland
Jessica Glen United Kingdom
Wojciech Sydor Poland
Cafer Adıgüzel United States
Vasiliki Karlaftis Australia
Paula F. Ypma Netherlands
Jason Coppell United Kingdom
Henk J Adriaansen Netherlands
G. Tamponi Italy
K. Rodriguez-Castro Italy
Yuan‐Bin Yu relative to Andrzej Rydzewski Poland Andrzej Rydzewski's profile →
Citations per field
00.5×
Andrzej Rydzewski · 1×
Citations per year

Countries citing papers authored by Yuan‐Bin Yu

Since Specialization
Citations

This map shows the geographic impact of Yuan‐Bin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan‐Bin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan‐Bin Yu more than expected).

Fields of papers citing papers by Yuan‐Bin Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan‐Bin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan‐Bin Yu. The network helps show where Yuan‐Bin Yu may publish in the future.

Co-authorship network of co-authors of Yuan‐Bin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan‐Bin Yu. A scholar is included among the top collaborators of Yuan‐Bin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan‐Bin Yu. Yuan‐Bin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 1
4 3
5
Cerebral microbleeds associated with critical illness.
4
6 5
7 9
8 6
9 33
10 13
11 38
12 2
13 90
14 55
15 40
16 2
17 1
18 20
19 24
20 19

About Yuan‐Bin Yu

Yuan‐Bin Yu is a scholar working on Hematology, Genetics and Oncology, having authored 35 papers that have together received 458 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Internal Medicine (52 citations), Hematology (154 citations) and Genetics (45 citations). Yuan‐Bin Yu has collaborated with scholars based in Taiwan, Belarus and Greece. Frequent co-authors include Jyh‐Pyng Gau, Liu H, Chun‐Yu Liu, Cheng‐Hwai Tzeng, Liang‐Tsai Hsiao, Yao Shen, Peir‐Haur Hung, Tzong‐Shyuan Lee, Chien‐Hung Lin and Po‐Min Chen. Their work appears in journals such as Blood, Journal of Cellular Physiology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026